BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 31

• Business

  Cell Medica Expands Management Team With Experienced Pharmaceutical Executives

  May 24, 2016

   · 

  4 min read
• Business

  BrightWater Medical Medical Closes Series A Financing

  May 24, 2016

   · 

  3 min read
• Business

  Appistry, Inc. Enters Partnership With Washington University in St. Louis

  May 24, 2016

   · 

  3 min read
• Drug Development

  Boehringer Ingelheim Release: IL-23 Inhibitor Risankizumab Induces Remission In Phase II Study In Patients With Moderate-To-Severe Crohn’s Disease

  May 24, 2016

   · 

  6 min read
• Genetown

  ZeOmega Integrating McKesson InterQual Connect Into Jiva

  May 24, 2016

   · 

  3 min read
• BioCapital

  The Science Advisory Board Release: Scientists Highlight Flaws In The Clinical Trial Process

  May 24, 2016

   · 

  4 min read
• Policy

  DSM Sinochem Pharmaceuticals Supports Fight Against Superbugs And Welcomes The Clear Recommendations Of The AMR Review

  May 24, 2016

   · 

  4 min read
• Drug Development

  AbbVie Release: IL-23 Inhibitor Risankizumab Induces Remission In Phase II Study In Patients With Moderate-To-Severe Crohn’s Disease

  May 24, 2016

   · 

  6 min read
• OrbusNeich Expands Portfolio To Treat Peripheral Disease

  May 24, 2016

   · 

  3 min read
• Policy

  Samsung Bioepis’ Biologics License Application For SB2 Infliximab Biosimilar Accepted By U.S. FDA

  May 24, 2016

   · 

  3 min read